The global non-invasive fat reduction market size was valued at USD 1.1 billion in 2021 and is anticipated to register a compound annual growth rate (CAGR) of 16.1% from 2022 to 2030. Non-invasive fat reduction is a fat reduction procedure that is done to decrease or eliminate the stubborn fat pockets in specific areas of the body by using methods like cryolipolysis, radiofrequency, and laser lipolysis. Non-invasive devices that are used in these procedures to permanently abolish fat cells are FDA approved as their efficiency and safety have been tested and the results have been proven to show significant results.
The advent of the COVID-19 pandemic has hugely affected the overall market. But many aesthetic professionals believe that the pandemic might most likely propel the overall aesthetic industry. Many dermatology clinics have witnessed a boost in the number of future appointments and consultations for different skin treatments and this is expected to boost the market growth. These procedures are to be carried out by professional practitioners who are technically sound to execute these treatments. Some of the famous brands for non-invasive fat reduction procedures are CoolSculpting, Kybella, Vanquish, and Sculpsure.
The Cryolipolysis technology segment is expected to witness a high CAGR of 16.5% over the forecast period. According to WHO, a sedentary lifestyle is a major underlying cause of obesity, disease, and disability. Approximately 2 million deaths every year are attributable to obesity. Physical inactivity, tedious & long working hours, behavioral risk factors like alcohol consumption, smoking, as well as stress are increasing the risk of an unhealthy lifestyle which has, in turn, led to conditions like diabetes and obesity. With the increase in urbanization, people have limited time to focus on their physical health and, therefore, look for alternate options to reduce stubborn fat.
Factors such as increasing acceptance and rising demand for body contouring treatments, rise in health care expenditure, and surging prevalence of the obese population are the key factors boosting the growth of the market. According to the U.S. Bureau of Economic Analysis, in 2019, Americans had 16.65 trillion dollars in Disposable Personal Income and per capita personal disposable income was $43,828. As there is an increase in the amount of money people possess for their expenses, they often tend to opt for an aesthetic procedure.
According to the International Society of Aesthetic Plastic Surgery, around 120,707 non-surgical fat reduction treatments were carried out on the male population, globally in 2020. The adoption of such procedures witnessed an increase in the male population and is expected to witness high demand in the future as well. This is because there are technological advancements that are taking place in this segment backed by quick dramatic results and benefits which leads to an increase in acceptance by people. The ease of conducting such procedures and their affordability are captivating millennials, even more, to opt for such treatments.
Despite the COVID-19 pandemic negatively impacting several industries, the market has witnessed an increase in procedures. In 2021, the market has witnessed high demand due to the backlog of 2020 and increased interest from people related to dermatological procedures. The non-invasive fat reduction market has witnessed high volatility during the past few months and is expected to return to its normal growth trend by 2023.
As reported by the International Society of Aesthetic Plastic Surgery, in 2020, the non-invasive fat reduction procedure witnessed a 21.2% growth indicating that adoption of the procedure has been on the rise globally.
The cryolipolysis segment held the highest market share of 34.1% in 2021. Cryolipolysis is a non-invasive method where cold temperatures are used to freeze and kill the fat in the targeted area which is then drained out of the body over two to six months by the metabolic pathways. According to the American Society of Aesthetic Plastic Surgery, 129,686 cryolipolysis procedures using Cool Sculpting were carried out in the U.S, in 2019.
People are choosing a minimal risk-related treatment that delivers instant and long-term results. The cryolopolysis segment demand is expected to boost also because it is more affordable, has very common complications like temporary discomfort, no downtime and a lot of campaigns have been launched by various key players for awareness regarding the safety and benefits of these devices. The other fast-growing technological segment is low-level lasers, wherein lower laser light of 635–680 nm wavelengths is used to liquefy targeted fat cells and permanently eradicate them.
The hospital segment held the highest market share of 52.2% in 2021. This is mainly because the hospital settings are well equipped with high-end technology, fat reduction devices, professional practitioners, and the necessary infrastructure to carry out such procedures, moreover, there is a sense of trust and reliability when the treatment is conducted in a hospital. Hospital accreditation is a crucial factor that positively further influences the patient preference for undergoing aesthetic procedures. The multispecialty clinic segment is also showing significant growth in the forecast period as they serve all the needs of the patients in one convenient location with procedural variations and the availability of skilled practitioners. The market as a whole is projected to have a very high demand in the coming years and showcase a high growth prospect leading to overall market growth and increased market revenue.
North America dominated the Non-Invasive Fat Reduction Market in 2021 with a 35.9% market share and this trend is expected to continue through the forecast period. According to the International Society of Aesthetic Plastic Surgery, the U.S. is the country with the most nonsurgical procedures and 3,182,815 treatments were carried out in 2020.
This can be attributed to, the rising obese population, increasing R&D in the region, the highest per capita disposable income, rising adoption of new technology, and constant awareness campaigns. The increasing need for perfect appearance and confidence through physical characteristics in the major fields of work is driving the regional market growth. The development of convenient procedures and easy access to healthcare facilities is proving to fuel the non-invasive fat reduction market in the country.
The Asia Pacific market is expected to witness the highest CAGR of 18.0 % over the forecast period. This is attributed to the low cost of treatment, rising patient awareness, availability and benefits of body contouring treatments, rising demand for aesthetics, cultural adoption from the western economies, and marketing strategies implemented by the key players in the market. The combination of all these factors will make the Asia Pacific emerged as the most promising, high-growth market in the forecast period.
The global market is highly competitive. Some of the players operating in the market are Fosun Pharmaceuticals Co. Ltd; Cutera Inc.; Cynosure LLC; Zeltiq Aesthetics; Syneron Candela; BTL Industries.; Lynton Lasers Ltd; and Venus concept. One of the key factors driving competitiveness among market players is the rapid adoption of advanced technology and improved result output.
Moreover, the competition between key players will turn intense in the coming years as they are focusing more on geographical expansion, strategic collaborations, and partnerships through mergers and acquisitions. The major players in the market are rigorously promoting their fat reduction workstations by making use of various marketing strategies For instance, In September 2020, Cutera announced the launch of truSculpt flex, which is the company’s body sculpting platform, in Canada. Some of the key players in the global non-invasive fat reduction market include:
Cynosure
Fosun Pharmaceuticals Co. Ltd
Cutera Inc
Zeltiq Aesthetics
Candela Corporation
BTL Industries
Venus Concept
Lynton Lasers Ltd.
Attribute |
Details |
Market size value in 2022 |
USD 1.3 billion |
Revenue forecast in 2030 |
USD 4.3 billion |
Growth rate |
CAGR of 16.1% from 2022 to 2030 |
Base year for estimation |
2021 |
Historical data |
2018 - 2020 |
Forecast period |
2022 - 2030 |
Quantitative units |
Revenue in USD million and CAGR from 2021 to 2028 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Technology, end-use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; Germany; U.K.; France; Italy; Spain; China; Japan; India; Australia; South Korea; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; |
Key companies profiled |
Alma Lasers GmbH; Cynosure, Inc.; Solta Medical, Inc.; Cutera, Inc.; Syneron Medical Ltd.; Canfield Scientific, Inc.; 3Gen; Aesthetic Group; Ambicare Health; and Image Derm, Inc. |
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2030. For this study, Grand View Research has segmented the global non-invasive fat reduction market report based on technology, end-use, and region:
Technology Outlook (Revenue, USD Million, 2018 - 2030)
Cryolipolysis
Ultrasound
Low-Level Lasers
Others
End-use Outlook (Revenue, USD Million, 2018 - 2030)
Hospitals
Stand Alone Practices
Multispecialty Clinics
Others
Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
U.K.
Germany
France
Spain
Italy
Asia Pacific
India
Japan
China
Australia
South Korea
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
b. The global non-invasive fat reduction market size was estimated at USD 1.1 billion in 2021 and is expected to reach USD 1.3 billion in 2022.
b. The global non-invasive fat reduction market is expected to grow at a compound annual growth rate of 16.1% from 2022 to 2030 to reach USD 4.3 billion by 2030.
b. North America dominated the non-invasive fat reduction market with a share of 38.6% in 2021. This is attributable to high personal disposable income, high expenditure on healthcare, a large pool of certified professionals, and the rising prevalence of obesity among the population.
b. Some key players operating in the non-invasive fat reduction market include Fosun Pharmaceutical Co. Ltd, Cutera Inc, Cynosure Inc, ZELTIQ Aesthetics Inc., Syneron Medical Ltd, BTL, Venus Concept, Lumenis Ltd., Candela Corporation, and Hologic Inc.
b. Key factors that are driving the non-invasive fat reduction market growth include the increasing prevalence of obesity and the rise in demand for non-invasive procedures.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
Leading SME award by D&B
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
"The quality of research they have done for us has been excellent."
We value your investment and offer free customization with every report to fulfil your exact research needs.